Immediate Impact

60 standout
Sub-graph 1 of 23

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Artificial intelligence in drug development
2025 Standout
3 intermediate papers

Works of Xiaojia Liu being referenced

Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
2020
Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Xiaojia Liu 750 288 255 294 63 1.3k
Siamak Sandoghchian Shotorbani 637 249 381 249 55 1.5k
Xiaofei Zhu 634 278 156 244 78 1.3k
Chao‐Wen Cheng 571 247 393 187 64 1.4k
She Chen 671 303 261 197 50 1.3k
Daejin Kim 814 341 446 302 75 1.7k
Mikhail Ryzhikov 803 331 126 304 69 1.4k
Kyung Song 1065 333 175 272 48 1.6k
Sandeep Kumar 744 338 314 319 62 1.5k
Wei Ma 753 202 360 370 67 1.6k
Hua‐Fu Zhou 924 202 197 349 52 1.6k

All Works

Loading papers...

Rankless by CCL
2026